BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20036815)

  • 1. Regulation of tumor angiogenesis by the local environment.
    Hall K; Ran S
    Front Biosci (Landmark Ed); 2010 Jan; 15(1):195-212. PubMed ID: 20036815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dll4-Notch signaling in regulation of tumor angiogenesis.
    Liu Z; Fan F; Wang A; Zheng S; Lu Y
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):525-36. PubMed ID: 24114288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic and lymphangiogenic cascades in the tumor microenvironment.
    Onimaru M; Yonemitsu Y
    Front Biosci (Schol Ed); 2011 Jan; 3(1):216-25. PubMed ID: 21196371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting angiogenesis in cancer therapy.
    Ichihara E; Kiura K; Tanimoto M
    Acta Med Okayama; 2011 Dec; 65(6):353-62. PubMed ID: 22189475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-like 4/Notch signaling promotes Apc
    Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
    BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
    Lopes-Coelho F; Martins F; Pereira SA; Serpa J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision.
    Boareto M; Jolly MK; Ben-Jacob E; Onuchic JN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3836-44. PubMed ID: 26153421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
    Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS
    Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis: from molecular mechanisms to translational implications.
    Li B; Xiu R
    Clin Hemorheol Microcirc; 2013; 54(4):345-55. PubMed ID: 23241508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
    Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
    PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.
    Mittal K; Ebos J; Rini B
    Semin Oncol; 2014 Apr; 41(2):235-51. PubMed ID: 24787295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis--characteristics of tumor endothelial cells.
    Hida K; Maishi N; Torii C; Hida Y
    Int J Clin Oncol; 2016 Apr; 21(2):206-212. PubMed ID: 26879652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
    Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
    PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
    Parmar D; Apte M
    Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.
    Longo V; Tamma R; Brunetti O; Pisconti S; Argentiero A; Silvestris N; Ribatti D
    Clin Exp Med; 2018 Aug; 18(3):319-323. PubMed ID: 29492715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review).
    Caporarello N; Lupo G; Olivieri M; Cristaldi M; Cambria MT; Salmeri M; Anfuso CD
    Mol Med Rep; 2017 Oct; 16(4):4393-4402. PubMed ID: 28791360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
    Oon CE; Harris AL
    Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.